Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals
Pharmaceutical Research · 2025
DOI: 10.1007/s11095-024-03810-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Research, 2025. Verfasst von Hui-Hsia Hsieh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan. Hauptthemen laut MEDLINE: Phytochemicals, Neoplasms, Epigenesis, Genetic, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Epigenetic modifications, such as aberrant DNA methylation, histone alterations, non-coding RNA remodeling, and modulation of transcription factors, are pivotal in the pathogenesis of diverse malignancies. Reactive oxygen species (ROS) have the capacity to impact these epigenetic mechanisms, including DNA methylation, throughout the different stages of cancer development. Therefore, the aim of this review is to address the impact of. METHODS: Published papers were searched in Pubmed and Google Scholar databases using the keywords "epigenetic", or "DNA methylation", or "phytochemicals", or "chemoprevention" to prepare this review. RESULTS: There is mounting evidence indicating that diminishing ROS accumulation within cells can regulate the function of DNA methyltransferases (DNMTs). Moreover, activation of the cellular defense system can impede and potentially reverse the progression of tumors in cancerous cells. As a result, ROS scavengers, antioxidants, and demethylating agents have emerged as potential therapeutic approaches for specific types of cancer. Additionally, dietary phytochemicals present in fruits, vegetables, and herbs, which have been utilized for centuries, exhibit the capability to modulate transcription factors, decrease inflammation, deliver antioxidant benefits, induce cell-cycle arrest, and stimulate apoptosis. CONCLUSION: These phytochemicals can also renew and reprogram the expression of genes that suppress cancer. Thus, prolonged exposure to phytochemicals at low doses represents an innovative therapeutic tactic for the prevention of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan.
- School of Pharmacy, China Medical University, Taichung City, Taiwan.
- Institute of Molecular Medicine and Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong Univer…
- Department of English, National Taichung University of Education, Taichung City, Taiwan.
- School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung City, Taiwan.
- Bergen County Academies, Hackensack, NJ, USA.
Zitieren
APA
Hsieh, H. H., Kuo, M. Z., Chen, I. A., Lin, C. J., Hsu, V., HuangFu, W. C., & Wu, T. Y. (2025). Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03810-2
Vancouver
Hsieh HH, Kuo MZ, Chen IA, Lin CJ, Hsu V, HuangFu WC, et al. Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals. Pharmaceutical Research. 2025. doi:10.1007/s11095-024-03810-2
BibTeX
@article{Hsieh2025,
author = {Hsieh, Hui-Hsia and Kuo, Min-Zhan and Chen, I-An and Lin, Chien-Ju and Hsu, Victor and HuangFu, Wei-Chun and Wu, Tien-Yuan},
title = {Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals},
journal = {Pharmaceutical Research},
year = {2025},
doi = {10.1007/s11095-024-03810-2}
}
EUVIMED